PATENT CLAIM ANALYSIS

Application Number: 15867985
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "450000"]

Abstract:
The present invention is directed to carrier systems comprising ether-lipids conjugated to one or more bioactive ligands and exposed on the surface of the carrier system for use in targeted delivery and/or antigen display systems. Optionally one or more further bioactive agents may be encapsulated or embedded within or attached to or adsorbed onto the carrier system. The present invention is further directed to methods of their preparation and their uses in medical applications, such as targeted delivery of bioactive agents to specific tissues or cells and antigen display systems for the study, diagnosis, and treatment of traits, diseases and conditions that respond to said bioactive agents.

Claim (Index 38):
The compound according to  claim 37 , wherein the at least one of X 1 , X 2 , X 3  that is a legumain targeting ligand group is RR11a.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 86.0
- Lexical Diversity: 1.78125
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14384702', '14385178', '12993421', '15495474', '11810931']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7152895819028381
- 35 USC 102 Novelty (BERT): 0.5522941244182352
- Combined Prediction Score: 0.6989900361543778
- Mean Citation Score: 278.593118
- Max Citation Score: 410.66608
- Similarity Product: 271.8058950203324

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test